Painkiller Medication Management and Use (MMU) After Bone Fracture Surgery: An AI-Supported Scientific Review.

Authors

  • Mohammed Ali Hamed Al-Nafie Author
  • Saleh Hya Abbad Al-Harbi Author
  • Mohammed Saad Al-OsImi Author
  • Mansour Mashour Talb Al-Otibi Author
  • Mohammed Shareef Algethami Author
  • Raed Oudah Al-Nefaie Author
  • Olayan Mohammed Turki Al-Subaie Author

DOI:

https://doi.org/10.64149/J.Ver.8.2.58-71

Keywords:

Percutaneous Bleomycin, Polidocanol, Peripheral Venous Malformations.

Abstract

Postoperative pain management following bone fracture surgery is a critical determinant of patient recovery, mobility, and satisfaction. Effective pain control must balance analgesic efficacy with medication safety, prevention of adverse drug events (ADEs), and rational use of opioids. This paper explores the principles of painkiller medication management after orthopedic fracture surgery within the Medication Management and Use (MMU) framework. Emphasis is placed on drug selection, dosing strategies, monitoring, patient education, and interdisciplinary collaboration. Evidence-based analgesic protocols, multimodal analgesia, and quality indicators aligned with international accreditation standards are discussed.

Downloads

Published

2025-10-15

How to Cite

Painkiller Medication Management and Use (MMU) After Bone Fracture Surgery: An AI-Supported Scientific Review. (2025). Vascular and Endovascular Review, 8(2), 58-71. https://doi.org/10.64149/J.Ver.8.2.58-71